CD24 and neoplasm: While this target has shown promise, as tumorigenesis and metastasis are often multicausal, involving dysregulation of multiple signaling pathways, in addition to CD47, we propose a combinatorial siRNA strategy to simultaneously silence CD24, CD44, and CD47, three distinct but interrelated molecules critical for tumor progression.